Innovatus Life Sciences Acquisition in a letter to the SEC said it is withdrawing an offering of 17.5 milion units that wer initially registered in April 2021. No warrants were included in the units.
The SPAC was planning to target companies in the life sciences sector.
Innovatus is led by CEO and Chairman David Schiff, a partner at investment firm Innovatus Capital Partners since its inception in 2015.
The SPAC had applied for a Nasdaq listing. Read more.
